SCHEDULE: RTW Funds Increase Stake in Orchestra Biomed Holdings

RTW Investments, LP and affiliated funds have increased their beneficial ownership in Orchestra Biomed Holdings, Inc. to 19.2% following the cashless exercise of pre-funded warrants.

Summary

• RTW Investments, LP, along with RTW Master Fund, Ltd. and RTW Innovation Master Fund, Ltd., have collectively increased their beneficial ownership in Orchestra Biomed Holdings, Inc.
• This increase in ownership to 19.2% is a result of the cashless exercise of pre-funded warrants on April 27, 2026.
• Specifically, 1,250,032 pre-funded warrants were exercised, resulting in the issuance of 1,250,000 shares of common stock to the RTW Funds.
• The total number of shares beneficially owned by RTW Investments, LP is 11,942,394.
• RTW Master Fund, Ltd. now beneficially owns 5,820,915 shares (9.6% of the class).
• RTW Innovation Master Fund, Ltd. now beneficially owns 4,931,714 shares (8.1% of the class).
• Roderick Wong, as Managing Partner of RTW Investments, may be deemed to beneficially own these shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it reflects increased investment and confidence from a significant shareholder, but does not contain operational or financial performance updates.

Positives

• RTW Funds have demonstrated continued conviction in Orchestra Biomed Holdings by exercising warrants and increasing their stake.
• The cashless exercise of warrants allows the RTW Funds to increase their share count without an immediate cash outlay, preserving capital.
• The aggregate beneficial ownership of 19.2% indicates a significant investment and potential influence in the company.

Negatives

• The filing does not contain any negative financial results or operational setbacks.
• The exercise of warrants implies a prior investment decision that may have been made at different price points.

Risks

• The increased ownership by RTW Funds could lead to greater scrutiny of their investment strategy and potential for activist involvement.
• The filing does not detail any specific risks related to Orchestra Biomed Holdings' operations or future prospects.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from Orchestra Biomed Holdings. The action described is a past event (warrant exercise).

Management Comments

• As the investment manager of the RTW Funds, RTW Investments may be deemed to own beneficially the shares of common stock held by the RTW Funds.
• As the Managing Partner of RTW Investments, Dr. Wong may be deemed to own beneficially the shares of common stock.

Industry Context

StockSavvy.ai notes that significant stake increases by investment funds, particularly through warrant exercises, often signal a belief in the company's future value or potential for strategic change. This filing indicates a concentrated ownership position by RTW Funds in Orchestra Biomed Holdings.

Stakeholder Impact

• Shareholders: The increased concentration of ownership by RTW Funds may influence future corporate decisions and potentially lead to changes in strategy or governance.
• Management: The significant stake held by RTW Funds could lead to increased engagement or pressure on the company's management.
• Creditors: No direct impact mentioned, but significant changes in ownership can indirectly affect a company's financial stability.

Next Steps

• The RTW Funds will continue to hold their increased stake in Orchestra Biomed Holdings.
• Further actions by RTW Funds, if any, will be disclosed in subsequent filings.

Key Dates

Recommendation

The filing indicates a significant increase in beneficial ownership by RTW Funds, demonstrating their confidence. However, it is an amendment to a Schedule 13D and does not provide new operational or financial performance data for Orchestra Biomed Holdings. Therefore, a 'hold' recommendation is appropriate pending further information on the company's performance and strategic direction.

Keywords

Orchestra Biomed Holdings, Schedule 13D, RTW Investments, RTW Master Fund, RTW Innovation Master Fund, beneficial ownership, pre-funded warrants, common stock, Roderick Wong, SEC filing, shareholder activism